PREVALENCE OF POLYCYSTIC OVARY SYNDROME IN NORMOGONADOTROPIC OVARIAN INSUFFICIENCY

Abstract

The aim of the study: diagnosis and assessment of the prevalence of PCOS in normogonadotropic ovarian insufficiency. Materials and Methods.This retrospective study was conducted based on the data of reproductive-aged female patients who visited the Republican Specialized Scientific and Practical Medical Center of Endocrinology from January 2019 to June 2023. The study represents an analysis of medical data collected over this period and aims to examine various aspects of health and the reproductive system in women of reproductive age. Results. A total of 56,977 reproductive-aged women visited the consultative polyclinic of the Republican Specialized Scientific and Practical Medical Center of Endocrinology between January 2019 and June 2023. Among them, 4,786 and 4,372 women had their FSH (follicle-stimulating hormone) and LH (luteinizing hormone) levels assessed, respectively. In 3,916 (81.8%) women, gonadotropic hormone levels (FSH, LH) were within the normal range. Among these, 572 women reported menstrual cycle disorders. Based on the 2018 Rotterdam criteria, 66% of these women were diagnosed with PCOS. Conclusions. In our study, we assessed the prevalence of PCOS among women with normogonadotropic ovarian insufficiency (class 2 anovulation according to WHO). PCOS was detected in 66% of the examined patients in this group.